Skip to main content

Table 9 Association between lipodystrophy and the metabolic syndrome and its individual components in men

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

  Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 3
OR (95% CI)
MS ATP III 1.017 (0.598-1.731) 0.621 (0.324-1.191) 0.931 (0.460-1.884)
High waist circumference 0.508 (0.260-0.991) 0.403 (0.187-0.865) --
Hypertriglyceridemia 1.846 (0.940-3.624) 1.677 (0.782-3.600) 2.019 (0.899-4.531)
Low HDL cholesterol 1.261 (0.686-2.319) 1.116 (0.562-2.216) 1.304 (0.639-2.661)
High fasting glucose 1.254 (0.734-2.143) 1.004 (0.540-1.868) 1.256 (0.654-2.409)
High blood pressure 0.905 (0.532-1.540) 0.458 (0.223-0.939) 0.567 (0.270-1.191)
MS IDF 0.694 (0.402-1.196) 0.519 (0.274-0.985) 1.058 (0.473-2.365)
High waist circumference 0.585 (0.342-1.001) 0.491 (0.260-0.929) --
Hypertriglyceridemia 1.846 (0.940-3.624) 1.677 (0.782-3.600) 2.019 (0.899-4.531)
Low HDL cholesterol 1.261 (0.686-2.319) 1.116 (0.562-2.216) 1.304 (0.639-2.661)
High fasting glucose 1.130 (0.661-1.931) 0.940 (0.506-1.743) 1.143 (0.599-2.180)
High blood pressure 0.905 (0.532-1.540) 0.458 (0.223-0.939) 0.567 (0.270-1.191)
  1. Model 1 - OR crude
  2. Model 2 - OR adjusted for gender, age and cART
  3. Model 3 - OR adjusted for gender, age, duration of cART and BMI